美國居民不適用 XM 服務。
F
F

FreseniusMedical

交易方向

交易者脈動

技術摘要

小時

財經新聞

U.S. STOCKS Nasdaq, Albemarle, Haemonetics

BUZZ-U.S. STOCKS ON THE MOVE-Nasdaq, Albemarle, Haemonetics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street fell on Tuesday, with weakness in megacap growth stocks such as Apple and Tesla weighing on the Nasdaq, while investors assessed a slew of economic data and awaited remarks from Federal Reserve Chair Jerome Powell.
A
N
S
T
A
F
U
U
D

Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data

CORRECTED-(OFFICIAL)-UPDATE 1-Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data Corrects paragraph 5 to say Ozempic cut the risk of death from kidney disease and major cardiac events (not just kidney disease) in diabetes patients by 24%, after company corrected its earlier information By Pratik Jain and Bhanvi Satija March 5 (Reuters) - Shares of dialysis services providers jumped between 3% and 12% on Tuesday as latest data from Novo Nordisk's NOVOb.CO h
F
N
D

Dialysis firms gain as Ozempic kidney trial data disappoints some investors

BUZZ-Dialysis firms gain as Ozempic kidney trial data disappoints some investors Updates ** Shares of dialysis firms DaVita DVA.N and U.S.-listed shares of Fresenius Medical FMS.N rise ~7 .2 % and 12 .8% respectively ** Shares of Baxter International BAX.N , which has a kidney care unit that also provides dialysis operations, gain 2 .7 % to ~$43 .6
F
N
D

Dialysis firms gain as Ozempic kidney trial data disappoints

Dialysis firms gain as Ozempic kidney trial data disappoints March 5 (Reuters) - Shares of dialysis services providers jumped in early trading on Tuesday after Novo Nordisk's NOVOb.CO popular diabetes drug Ozempic fell short of some expectations when tested on patients with chronic kidney disease. Colorado-based DaVita DVA.N rose 7.4%, while the U.S.-listed shares of rival Fresenius Medical FMS.N were up 9.5% in early trading.
F
N
D

Fresenius Medical Care Announces Sale Of Dialysis Clinics In Brazil, Colombia, Chile, Ecuador

BRIEF-Fresenius Medical Care Announces Sale Of Dialysis Clinics In Brazil, Colombia, Chile, Ecuador March 5 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE : FMC AG - FRESENIUS MEDICAL CARE ACHIEVES NEXT MILESTONE IN PORTFOLIO OPTIMIZATION PROGRAM, ANNOUNCING SALE OF DIALYSIS CLINICS IN BRAZIL, COLOMBIA, CHILE, ECUADOR FMC AG - DIVESTMENT OF ASSETS INCLUDES FOUR SEPARATE COUNTRY TRANSACTIONS TO DAVITA INC.
F

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明